v3.25.4
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities:      
Net earnings (loss) $ (23,281) $ (31,268) $ (125,294)
Adjustments to reconcile net earnings (loss) to net cash provided by (used in) operating activities:      
Depreciation and amortization 75,634 62,829 70,980
Stock-based compensation 15,575 16,519 13,221
Impairment expense 30,131    
Share of (earnings) losses of affiliates, net (29,433) (30,460) (26,985)
Realized and unrealized (gains) losses on intergroup interests, net     83,178
Realized and unrealized (gains) losses on financial instruments, net 1,001 (3,424) (2,343)
(Gains) losses on dispositions, net     (2,309)
Deferred income tax expense (benefit) (2,440) (9,288) (7,872)
Cash receipts from returns on equity method investments 21,150 21,602 22,450
Net cash received (paid) for interest rate swaps 2,265 5,794 5,104
Other charges (credits), net 6,547 1,855 1,218
Net change in operating assets and liabilities:      
Current and other assets (57,040) (15,827) (42,802)
Payables and other liabilities (14,873) (1,701) 13,080
Net cash provided by (used in) operating activities 25,236 16,631 1,626
Cash flows from investing activities:      
Capital expended for property and equipment (51,333) (86,013) (69,036)
Acquisition of real estate assets (93,709)    
Investments in equity method affiliates and equity securities   (334) (125)
Other investing activities, net 6 40 110
Net cash provided by (used in) investing activities (145,036) (86,307) (69,051)
Cash flows from financing activities:      
Borrowings of debt 158,162 144,890 83,033
Repayments of debt (41,493) (102,415) (56,187)
Contribution from noncontrolling interest     12,045
Proceeds (disbursements) from exercise of stock options and other stock issuances 9,055 6,412 (689)
Other financing activities, net (6,945) (4,329) (5,873)
Net cash provided by (used in) financing activities 118,779 44,558 32,329
Net increase (decrease) in cash, cash equivalents and restricted cash (1,021) (25,118) (35,096)
Cash, cash equivalents and restricted cash at beginning of period 112,599 137,717 172,813
Cash, cash equivalents and restricted cash at end of period $ 111,578 $ 112,599 $ 137,717